Wiltrud LEDERLE
2Patents
0h-index
5Co-inventors
24Inventor score
Filing activity: May 25, 2018 → Dec 31, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11517622B2 | Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer | Human Necessities | 0 | Active |
| US11951166B2 | Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.